21 JAN 2019 MERGERMARKET
Louise Weihart in Sydney
Anatara Lifesciences [ASX:ANR], an Australian developer of treatments for gastro-intestinal conditions with unmet medical need, is actively seeking deals to bolster its gastro-intestinal pipeline as it moves its focus to human health, said new Chief Executive Officer Steven Lydeamore.
For the full article, please click here –
190121 – Mergermarket – Anatara Lifesciences seeks deals to bolster human health